Skip to main content
GettyImages-1266187249

Engineering's Umut Gurkan says that sickle cell disease treatments have been fairly limited for decades

MEDIA | April 21, 2021
STORY BY: EDITORIAL STAFF

A new clinical trial will explore gene editing for sickle cell disease

Verywell Health: Umut Gurkan, the Warren E. Rupp Associate Professor in the Department of Mechanical and Aerospace Engineering, said that medication treatment options for sickle cell disease have been fairly limited for decades.